Press Releases

Sep 06, 2023
SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer
NEW YORK , Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO).
Aug 08, 2023
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
- In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corpor ate Update Conference Call Today at 4:30 PM ET - NEW YORK , Aug. 08, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage
May 04, 2023
SIGA Reports Financial Results for Three Months Ended March 31, 2023
- Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK , May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2023 .
May 04, 2023
SIGA Declares Special Cash Dividend of $0.45 Per Share
NEW YORK , May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special cash dividend of $0.45 per share on the common stock of the Company.
Displaying 1 - 10 of 12